2010



2010

Morko, J., Peng, Z.Q., Vääräniemi, J., Rissanen, J.P., Suominen, M.I., Fagerlund, K.M., Suutari, T.A., Boonen, H.C.M., Neerup, T.S.R., Bak, H.H., Halleen, J.M.
A novel cyclic PTH(1-17) analog with bone anabolic activity and efficacy sufficient to treat established osteopenia in adult ovariectomized.
Poster abstract (SU0418) at American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting, October 15 - 19, 2010, Toronto, ON, Canada
J Bone Miner Res. 2010, 25 (Suppl 1): S344.
Poster

Halleen, J.M., Peng, Z.Q., Fagerlund, K.M., Suutari, T., Vääräniemi, J., Suominen, M.I., Rissanen, J.P., Boonen, H.C.M., Neerup, T.S.R., Bak, H.H., Morko, J.
Monitoring of intermittent PTH(1-34) treatment by serum PINP in adult ovariectomized osteopenic rats
Poster abstract (SA0423) at American Society for Bone and Mineral Research (ASBMR) 2010 Annual Meeting, October 15 - 19, 2010, Toronto, ON, Canada
J Bone Miner Res. 2010, 25 (Suppl 1): S213
Poster

Daugaard, J.R., Meier, E., Riber, D., Bæk, C.Æ. and Larsen, K.:
The New Dual Glucagon-GLP-1 Agonist ZP2929 Acutely Improves Glycemic Control in High Fat Fed C57BL/6J Mice
Abstract for Keystone January 12 - January 17, 2011, Keystone, Colorado
Poster Number: 140, page 86 in abstract book.

Daugaard, J.R., Riber, D., Larsen, K., Meier, E., Bæk, C.Æ., Kampen, G.
The New Dual Glucagon-GLP-1 Agonist ZP2929 Improves Glycemic Control and Reduces Body Weight in Murine Models of Obesity and insulin resistance
Poster at EASD 46th Annual Meeting, Stockholm, Sweden, Sep. 20-24, 2010
Diabetologia, 2010, 53, Suppl 1, S354-S354
Poster

Becker, R.H.A, Ruus, P.; Liu, Y.-H. and Kapitza, C.:
Restoration of insulin release with lixisenatide in patients with type 2 diabetes.
Poster 850 at EASD 46th Annual Meeting, Stockholm, Sweden, Sep. 20-24, 2010
Diabetologia, 2010, 53, Suppl 1, S339
Poster

Gerich, J.E., Fonseca, V.A., Alvardo-Ruiz, R., Raccah, D., Zieleniuk, I., Boka, G., and Miossec, P.:
Monotherapy with GLP-1 receptor agonist, Lixisenatide, significantly improves glycaemic control in type 2 diabetic patients.
Poster 830 at EASD 46th Annual Meeting, Stockholm, Sweden, Sep. 20-24, 2010
Diabetologia, 2010, 53, Suppl 1, S330
Poster

Werner, U., Haschke, H., Herling, A.W., Kramer, W.:
Pharmacological profile of lixisenatide: A new GLP-1 receptor agonist for the treatment of type 2 diabetes.
Regulatory Peptides  2010, 164, 58–64

Daugaard, J.R., Meier, E., Riber, D., Bæk, C.Æ., Larsen, K., Kampen, G.:
The New Dual Glucagon-GLP-1 Agonist ZP2929 Improves Glycemic Control and Reduces Body Weight in Murine Models of Obesity and insulin Type 2 Diabetes.
The American Diabetes Association’s (ADA) 70th Scientific Sessions, 25-29 June, 2010, Orlando, FL, USA
Diabetes, 2010, 59, Suppl 1,1630-P, p A430
Poster

Axelsen, L.N., Pedersen, H.D., Petersen, J.S., Holstein-Rathlou, N-H. and Kjølbye, A.L.
Metabolic and cardiac changes in high cholesterol–fructose-fed rats
J Pharmacol.Toxicol.Methods, 2010, 61, 292-296

Axelsen, L.N., Lademann, J.B., Petersen, J.S., Holstein-Rathlou, N.-H., Ploug, T. Prats,C., Pedersen, H.D., and Kjølbye, A.L.
Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation.
Am.J Physiol Regul.Integr.Comp Physiol, 2010, 298, R1560-R1570

Knudsen, C.B. and Jensen, A.L.
Simultaneous Quantitative Determination of ZP1848 and Two Metabolites in Human Plasma Using Immunoaffinity-Precipitation LC/MS/MS
“2010 AAPS National Biotechnology Conference” in San Francisco, CA, USA, May 16-19 2010
Poster

Solomon, D.H.
Turning Peptides into Drug
“PepCon-2010” in Beijing, Kina, March 21-23 2010
Oral presentation

Larsen, B.D., Verma, V. Coombs, W., Lin, X., Spagnol, G., Sorgen, P.L., Taffet, S., and Delmar, M.
Discovery of novel small peptidomimetics that prevent cardiac gap junction closure and action potential propagation block. - From a 34 amino acid peptide RXP-E to active 3 amino acid peptide mimetics
“PepCon-2010” in Beijing, Kina, March 21-23 2010
Abstract
Oral presentation

Delmar, M, Lewandowski, R., Procida, K., Vaidyanathan, R., Coombs, W., Jalife, J., Nielsen, M.S., Larsen, B.D., Taffet, S.M.
RXP-E: A Cx43-binding peptide that prevents action potential propagation block
“PepCon-2010” in Beijing, Kina, March 21-23 2010
Abstract
Oral presentation

Ellegaard, M., Thorkildsen, C., Petersen, S., Petersen, J.S., Jørgensen, N.R., Just, R., Schwarz, P., Ramirez, M.T., Stahlhut, M.
Amylin(1-8) is Devoid of Anabolic Activity in Bone
Calcif.Tissue Int., 2010, 249-260

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.